Cita APA

Schiff, D., Jaeckle, K. A., Anderson, S. K., Galanis, E., Giannini, C., Buckner, J. C., . . . Sarkaria, J. N. (2018). Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. Cancer.

Citación estilo Chicago

Schiff, David, et al. "Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients With Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572." Cancer 2018.

Cita MLA

Schiff, David, et al. "Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients With Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572." Cancer 2018.